top of page
KULKA IS A MAJOR SUPPORTER OF THE LEUKEMIA LYMPHOMA SOCIETY.
HERE IS WHAT LLS IS DOING TO SUPPORT BLOOD CANCER.
LLS INVESTED MORE THAN
$1.6B
IN CANCER RESEARCH SINCE 1949
FUNDED MORE THAN
200
RESEARCH GRANTS AROUND THE WORLD
MORE THAN
$234M
IN CO-PAY FINANCIAL ASSISTANCE
HELPED ADVANCE
70%
OF THE BLOOD CANCER TREATMENTS APPROVED BY THE FDA SINCE 2017
Kulka CEO has helped raise over $1M for LLS
Since 2017, Devin Kulka has been an active member of the LLS Board. Devin has personally helped raise over $1M for the Leukemia Lymphoma Society by organizing fundraising events, reaching out to potential contributors, and leveraging his network to spread awareness and encourage donations.
Kulka's Connection to Blood Cancer
In 2020, Rob Mannino, COO at Kulka was diagnosed with Essential Thrombocytosis, a rare blood cancer where the body produces too many platelets, increasing the risk of blood clots, bleeding, and other complications. Although his disorder is not curable, with treatments similar to the ones funded by LLS, his cancer is manageable and maintainable.
bottom of page